For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
Before You Checkout
Bundle complementary compounds together — priced below buying each separately.
A synthetic peptide compound investigated for its binding interactions at GLP-1R, GIPR, and GCGR receptor systems. Used exclusively in preclinical in-vitro research settings to study multi-receptor pharmacodynamics, downstream cAMP signaling, and receptor binding kinetics.
Select Size
Dosage
10mg
Purity
99.2%
Form
Lyophilized Powder
Third-Party Tested
HPLC & mass-spec verified · every batch
Every batch is independently verified by HPLC and mass spectrometry to 99.2% purity and ships with a lot-specific Certificate of Analysis.
View all certificatesBOGO Sale — Buy More, Get More Free
Discount applied automatically in cart.
$49.95
Research Application Guidelines
This research compound is designed exclusively for controlled in vitro studies carried out by trained professionals. It is not intended for human or animal use and must not be incorporated into foods, cosmetics, medications, or diagnostic processes.
Regulatory Notice
This material has not been evaluated by the FDA and is not sold for the purpose of diagnosing, treating, curing, or preventing any condition. All handling, storage, and research use must comply with applicable regulations and institutional requirements.
Purchase & Responsibility Agreement
By purchasing from Ascension Labs, the buyer confirms that they are a qualified researcher or authorized laboratory. All sales are final. The buyer assumes full responsibility for the proper handling, storage, usage, and regulatory compliance of this material.
What's Included
Storage Guidelines
Quality Assurance
Disclaimer: Our peptides are research-grade products for laboratory use only. They are not approved for human consumption or medical use. Always follow proper laboratory safety protocols.
GLP-3RT is a synthetic multi-receptor peptide studied in vitro for binding at the GLP-1R, GIPR, and GCGR receptors. It is used to investigate multi-receptor pharmacodynamics and downstream cAMP signaling.
Also referred to as: GLP-3 (RT), retatrutide, LY3437943, triple agonist peptide, GLP-1/GIP/GCGR peptide.
In vitro pharmacology characterizes GLP-3RT as a synthetic triple agonist that binds and activates three class B G-protein-coupled receptors: GLP-1R, GIPR, and GCGR. Receptor engagement is studied through stimulation of intracellular cAMP accumulation, and researchers profile the relative potency at each receptor to map its multi-receptor signaling signature in cell-based assays.
GLP-3RT is a single-chain synthetic peptide belonging to the incretin-analog class, engineered as a unimolecular triple receptor agonist. Rather than citing an exact molecular weight, it is best characterized structurally by its combined agonist activity across the GLP-1, GIP, and glucagon receptor families, a design intended for multi-receptor pharmacology research in controlled in-vitro systems.
In selectivity studies, dual agonists engage two receptors, typically GLP-1R and GIPR. GLP-3RT adds meaningful agonist activity at the glucagon receptor (GCGR), giving it a three-receptor profile. This distinction is examined in comparative cAMP assays, where the additional GCGR component produces a broader signaling footprint than two-receptor compounds under identical laboratory conditions.
Yes. Every batch of GLP-3RT is independently tested by HPLC and mass spectrometry, and ships with a lot-specific Certificate of Analysis verifying 99.2% purity and molecular identity.
Store lyophilized GLP-3RT at -20°C for long-term storage or 2-8°C short-term. After reconstitution, keep refrigerated at 2-8°C and avoid repeated freeze-thaw cycles.
No. GLP-3RT is sold strictly for in-vitro research and laboratory use only. It is not a drug or supplement and is not intended for human or animal consumption.